This article showcases Startup Pill’s top picks for the best Pharmaceutical startups. These startups are taking a variety of approaches to innovating inside of the Pharmaceutical industry and around the world. They are all exceptional startups well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Join our community: The Startup Pill Facebook group is designed to be a friendly and international space where startup founders, investors and consultants can share resources, progress and tips. Click here to join.
Top Pharmaceutical Startups
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.. .
MindMed discovers, develops, and deploys psychedelic-inspired medicines and therapies to address addiction and mental health illness. The company is actively acquiring or forming collaborations for new clinical trials of hallucinogenic doses of psychedelics through human clinical trials.
It was founded by JR Rahn, Scott Freeman, Leonard Latchman, and Stephen L. Hurst in 2010..
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions. The company is dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
It was founded in La Jolla, California in 2020.. .
A leading biotech company focused on progressing psychedelic medicines. We’re developing novel therapeutics , delivery methods and treatment regiments in mental health disorders like MDD , ADHD , TRD.
Cybin currently has 8 Patent applications filling to date covering modified tryptamine and phenethylamine compounds and formulations. .
Adagio Therapeutics is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses. We believe our antibodies will match or exceed the potency and coverage of conventional SARS-CoV-2 antibody programs and can be used as both therapeutic and durable prophylactic treatments.
Our candidates are engineered using best-in-industry antibody discovery capabilities and are designed to maximize potency and duration of effect. Our portfolio includes multiple, non-competing antibodies with distinct binding targets, enabling a strategy that can avoid viral escape..
PostEra uses machine learning to close the design-make-test loop of drug discovery and reduce our clients’ cycle times. We are currently leading an international team of scientists to find a COVID antiviral via on open science initative.
Consider contributing your expertise to the initiative here: https://postera.ai/covid. .
BigHat Biosciences aims to radically reduce the difficulty of designing antibodies and other therapeutic proteins. Our AI-first experimental platform integrates a high-speed wet lab with artificial intelligence / machine learning (AI/ML) techniques and enables drug developers to create better antibodies faster and undertake novel biotherapeutic designs far beyond what’s possible today.
BigHat is a well-capitalized, seed-stage biotechnology company based in San Carlos in the Bay Area outside of San Francisco.. .
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders.
Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarily affecting girls that enable clients with providing therapy for it. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands..
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Its pipeline products include Olinciguat, Praliciguat, and others.. .
Somai Pharmaceuticals Ltd
Michael Sassano is the current CEO and Chairman of the Board for Somai Pharmaceuticals LTD, an Ireland-based company focused on cultivation and production of cannabinoid-containing pharmaceutical products throughout the European Union. Somai emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system, effectively and with consistency across markets.
Somai currently has offices in Ireland, Germany, Portugal, Switzerland, Greece, UK and Israel. The current focus of Somai Pharma is building scalable high out-put cultivation and extraction facilities in various strategic countries as Europe develops its market.
As the continent ultimately comes online, Somai will be positioned as one of the top global pharmaceutical distributors of medical-grade, EU-GMP certified cannabis. Somai’s method of development is scalability-based, matching the pace of Europe’s cannabis industry growth.
Somai’s first phase is in development in Portugal, focusing its operations on extraction. Portugal’s facility will be starting out at a fraction of the capacity it will be able to reach.
It will begin its extraction operations at 30,000 sq ft, with the ability to expand the project to reach up to 60,000 sq ft, which will more than satisfy current and future demand in Europe until 2024. Their second phase is a cultivation and extraction facility in Greece which is currently is in license and development stages.
The initial 12 acres of land in Kalamata will start as a 20,000 sq ft operations and extraction lab which can scale upto 50,000 sq ft. And, an initial 40,000 sq ft of greenhouse which can scale upto 300,000 sq ft.
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds – doctors, scientists, techies, and citizens – on a mission to offer the best of medicine without the baggage of rehab.
They are driven by science, committed to privacy, and bound to the client’s right to make their own choices. They believe in recommendations, not orders.
It was founded in 2019 and is based in Philadelphia, Pennsylvania.. .
Secura Bio is an integrated biopharmaceutical company committed to giving patients access to innovative therapies. Its a diagnosis of a serious illness can change life in an instant and finding treatment options is key.
At Secura Bio, they see things differently. They develop and commercialize innovative medicines and life-changing products for the patients that need them most.
Secura Bio was founded in 2019 and is headquartered in Las Vegas, NV, and has operations in the U.S. and offices in San Diego..
Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success. How? Just like an AI can learn to play chess, Aqemia’s generative AI learns to invent relevant compounds thanks to unique Statistical Mechanics algorithms predicting drug-target affinity among other properties.
Aqemia differentiation lies in its affinity prediction both accurate and 10 000x faster than competition, enabling efficient guidance of generation towards compounds with better chances to become drugs. Aqemia is a spin-off of École Normale Supérieure leveraging disruptive algorithms from 8 years of research.
Aqemia’s team is composed of high profiles at the crossroads of Medicinal Chemistry, Statistical Mechanics and Artificial Intelligence.. .
Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders. The company’s drugs treat neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders, enabling patients suffering from central nervous system disorders to recover with ease.
They developing innovative new chemical entities (NCE’s) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise.. .
Engrail is forging a new direction to reduce the enormous burden of diseases that impact the nervous system. We unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines.
Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.. .
Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases. Its proprietary pipeline includes multiple programs with broad clinical utility.
Longboard is evaluating LP352, a next-generation 5-HT2C agonist, in development for the potential treatment of developmental and epileptic encephalopathies, or DEEs. Longboard is also evaluating LP143, a centrally acting, full agonist of the cannabinoid type 2 receptor (CB2), and LP659, a centrally acting, next-generation, highly selective S1P receptor modulator..
Disco is a personal-care brand that offers a one-stop-shop for skincare products for men. The shop offers body wash, face moisturizer, deodorant, face scrub, face cleanser, and face mask.
Its aim is to solve frustrations with the men’s grooming market: lack of simplicity, confusion, and shortage of education. Benjamin Smith established the brand and is headquartered in Austin, Texas..
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics.
It was founded in 2020 and headquartered in Boston, Massachusetts.. .
Make your life easier, automate the machine learning process. JADBio automatically searches for the best algorithms, runs the preprocessing, selects the right features, tunes for hyper-parameters, and produces the final model and predictive performance, with lots of visualizations, graphs, and reports.
JADBio can credibly process small sample sizes and large feature sets, or produce multiple feature subsets that lead to equally predictive models for knowledge discovery.. .
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body’s immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies.
It was founded in 2019 and is based in Boston, Massachusetts.. .
Xilis is an oncology and precision health company that diagnosed cancer and find the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster.
It was founded in 2019 and is headquartered in Chapel Hill, North Carolina.. .
ShiftPosts allows shift workers to make more, and business owners to spend less. We are eliminating the middleman in relief shift work.
Our first stage is connecting pharmacy owners with relief pharmacists. In the near future, we will be expanding to further healthcare sectors.
ShiftPosts will be the number one place to be to connect businesses with shift workers. For Pharmacists: ShiftPosts puts the pharmacist in control of the shifts worked.
Pharmacists are able to customize their profile in order to find shifts that work best for them. Once their profile is set up, they can apply to the shifts of choice conveniently through the app.
For Pharmacies: Finding relief shift workers has never been easier. Pharmacists can be found anytime all through the app.
Simply send shift requests to pharmacists and receive applicants in minutes! www.shiftposts.com. .
Kansas is a global healthcare company specialized in medical devices, diagnostic solutions, nutrition, and branded generic pharmaceuticals businesses. Our medical and diagnostic equipment products are widely used around the world by hospitals, laboratories, blood banks, and healthcare centres to diagnose and monitor diseases.
Connect with us at www.kansaslaboratories.com and on Instagram @kansaslaboratories 堪萨斯州是一家全球性医疗保健公司，专门从事医疗设备，诊断解决方案，营养和品牌仿制药业务。 我们的医疗和诊断设备产品在全球范围内被医院，实验室，血库和医疗中心广泛用于诊断和监测疾病。 通过www.kansaslaboratories.com和Instagram @kansaslaboratories与我们联系. .
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precise target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored.
It was founded in 2019 and is headquartered in San Diego, California.. .
Generian team has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks linked to quality control and metabolism. Activation of these validated networks represents a unique approach with applicability across a broad range of chronic diseases.
Led by top researchers in the fields of aging, small molecule drug development, and E3 ubiquitin ligase biology, Generian’s platform will transform how we treat a wide array of both rare and common conditions using small molecules to reset and restore cellular homeostasis.. .
Aspargo Laboratories commercialize the rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients with dysphagia (trouble swallowing).
The company is developing patient-focused solutions and medicines by combining our innovative science and technology. Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRA Currently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China.
Applications for approval are planned for Croatia, France, Germany, and Austria.. .
JOGO is a Digital Therapeutics (DTx) uses the clinically proven science of neuroplasticity and biofeedback to treat patients with neuromuscular conditions and chronic pain. JOGO is composed of wearable sensors, and a patent protected Mobile App that leverages AI/ML and VR to provide treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuro-muscular re-education.
JOGO therapy is provided as JaaS (JOGO as a Service) at a doctor’s office, home visit or via Telemedicine by certified JOGO therapists. JOGO received FDA 510K exemption in March 2020 during COVID-19 pandemic and JaaS is reimbursed by Medicare and commercial payers under neuro-muscular re-education..
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.. .
Kanaph Therapeutics is a biotech with activities that range from drug discovery to early-stage clinical trials. We are dedicated to developing next-generation therapeutics for oncology and autoimmune diseases.
Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor microenvironment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well..
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. The company’s first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery.
Anodyne Nanotech was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.. .
Woolsey Pharmaceuticals is a pharmaceutical company that specializes in reinventing ways to treat some of the world’s most challenging diseases. The company’s approach allows them to accelerate the delivery of medicines for the benefit of all humankind.
The company was founded in 2019 and is headquartered in New York, United States.. .
Scienture is an operator of a pharmaceutical research company used to focus on drug screening. It focuses on the research and development of specialty product concepts that enable researchers to focus on the advancement of novel drugs in areas of unmet medical needs.
The company’s assets in development are across therapeutics areas, indications, and cater to different market segments focusing on the unmet medical needs of patients through innovative pharmaceutical products.. .
Elix is a personalized clinically-backed herbal remedies brand for women’s hormonal health. The company’s medicine is developed with the ancient Chinese medicine know-how in conjunction with modern medicine and the medicines contain a plant-based formula that is made with all-natural herbs with no artificial sweeteners, colorants, synthetic fillers, or chemicals, enabling physicians to meet the needs of women’s menstruation cycle.
Elix was founded in 2019 and is headquartered in New York, NY.. .
Medzino is a telemedicine brand offering Rx treatments for a range of conditions for men’s health, women’s health and general health where a face to face visit to the doctor is not required. Patients can use our asynchronous platform to request treatments for a list of embarrassing conditions from the comfort of their home and have their treatments delivered to their door.
We are a team of doctors, pharmacists, engineers and technical minded people on a mission to make healthcare more accessible, affordable and stress free.. .
Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures. Its novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers.
Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing. It is headquartered in Needham, Massachusetts..
Elysium provides a decentralized platform based on blockchain technology to securely share confidential health data between patients, doctors and healthcare facilities. By exploiting a decentralized data exchange protocol, it aims to encourage the exchange of medical records, therapies and drugs and can be extended to include any other type of shareable data.
This protocol is intended to incentivize the exchange of medical records, therapies and drugs to help physicians getting access to certified health data in a timely and transparent manner, reducing the risk of malpractice and improving patients’ outcomes for increasing transparency on personal liabilities and improving coordination across departments. We want people to be able to move all around the world without the worry that the best treatments cannot be provided because of the lack of their medical data.
We strongly believe patients should own their personal health data and be able to easily share it across applications.. .
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges.
With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases.
By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California..
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation. Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo.
The company is based in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education..
Elgia Therapeutics is a biotechnology company that specializes in novel approaches for the treatment of chronic inflammatory and fibrotic diseases. It specializes in the fields of healthcare, therapeutics, pharmaceutical, and medicine.
It was founded in 2019 and headquartered in San Diego, California.. .
LENUS BIOSCIENCES SPAC
LENUS BIOSCIENCE SPAC targets to acquire a conglomerate of companies in the area of medical cannabis (R&D, pharmaceutical production, distribution of pharmaceutical products) that create synergies and bring new technologies and a new approach in their business combination together. LENUS IS A MEDICAL BIOTECH PROJECT – dealing with drug nanospheres and medical cannabis.
WE ARE DEDICATED TO BRING LENUS TO A SUCCESSFUL IPO – Using a Special Purpose Acquisition Company we focus on the acquisition of promising companies with forward-looking technologies in the pharmaceutical sector and have experience in the medical CBD/THC R&D. IT IS OUR OUTSTANDING VISION TO HAVE IMPACT ON THE MARKET – Nano-Biotech plus CBD /THC will create new drugs and improve the efficiency of proven active ingredients.
IT IS OUR STRATEGY TO ACQUIRE POTENTIAL AND CREATE SYNERGIES – Acquire or cooperate with companies that have a proven track record in R&D or are hidden champions in the pharmaceutical market. PEOPLE MAKE THE DIFFERENCE – We work together with experts and institutions who are enthusiastic about making this project a success and who want to pass on their long-standing expertise.
Listing at Nasdaq planned; IPO proceeds are planned to be USD 90 – 150 million, S1 to be filed in May 2020. Required pre-IPO capital (sponsor capital) is USD 4.5 – 7.5 million, of which 4.5 M have been raised – there is still a short-term opportunity for pre-IPO investors (sponsors) to invest up to USD 3 M.
Sponsors will be provided with founder shares plus one full warrant for each USD invested. The Board of LENUS will consist of industry specialists, respective communication with prospective board members reached its final stage.
The only open Board position is the position of the CFO. We are looking for CFO candidates with track records in managing public companies, preferably from the cannabis and/or pharma industry..
CrossBridge Health is a software platform to connect physicians and payers to deliver evidence-based care with cost efficiency. Its technology integrates and aggregates patient data into a common platform, providing a longitudinal view of patient care.
Their clinical and financial analytics measure compliance with care pathways and support VBC models for chronic conditions. The CrossBridge platform produces actionable data that optimizes treatment plans, identifies gaps in care, integrates with current systems via an API, and provides measures of care quality and outcomes.
CrossBridge operationalizes and scales Value-Based Payment Models with incentives for cost savings and outcome improvements. They are leading the way in Value-Based Pharma Reimbursement, where the contracted price of a drug is data-driven, transparent, reproducible, and based on its measurable benefits – and where Outcomes-Based Pharma Reimbursement is based on the drug’s performance with actual patients..
MONTKUSH is an agriculture company that develops exclusive farms to oil CBD extract that is 100% organic. The company cultivates organic hemp-based CBD that is used in all our natural wellness products and create the products ourselves to maintain the integrity of the plant as mother nature intended.
The company is farming the highest quality CBD genetics using certified organic practices in the heart of Vermont. Each tincture maintains the naturally occurring concentrated compounds to provide the maximum power of full-spectrum CBD.
MONTKUSH was founded by Anthony Sullivan and Dave Christian in 2019 and is headquartered in Plainfield, Vermont, USA.. .
Comprehensive dashboard to research biotech. An online university with free courses explaining everything from the drug approval process to how drugs work and more.
An algorithm that alerts you whenever any significant event occurs, from catalysts to FDA drug approvals to stock dilutions and more.. .
Sisu Pharma is dedicated to developing targeted drugs for patients with therapy-resistant Prostate Cancer. Prostate Cancer is the second most common cancer in men worldwide and there were over 1.3 million new cases of the disease globally in 2018.
There are several treatments available for Prostate Cancer but none are curative and prolonged treatment inevitably results in resistance and death. Sisu Pharma’s proprietary technology specifically targets a key protein that is critical to the survival and spread of advanced Prostate Cancer, providing desperately needed treatment for patients with no remaining options..
Hemp2Lab refines how CBD oil is produced, bringing much-needed consistency and reliability to a newly evolving market. They cultivate it on organic-certified farms with sustainable growing practices and safeguard it using the most advanced processing technology and reputable third-party testing.
Seed-to-shelf and face-to-face, Hemp2Lab stands accountable and committed—to the farmers, customers, and the communities they share. It was founded in 2019 and is headquartered in Rossville, Tennessee..
Saliency automates your medical imaging workflow for clinical trials. It halves your turnaround time for quality control, preparation of images for physician review, and image annotations.
Solutions are customized for your imaging modality and therapeutic area. Learn about all the ways Saliency can enhance your work..
Healthcare marketplace is broken from a long-time. Both buyers (hospitals, health systems) and suppliers (pharmaceutical and medical device manufacturers/digital health companies/service or solution providers) struggle to find the optimum opportunities for developing a transaction.
It takes time and resources to effectively commercialise new healthcare technology. We use the latest data automation technologies (NLP, ML, DL etc).
to aggregate demand from millions of sources and provide real-time analytics to shape the transaction. We aggregate more than £1.5tn of global demand in our system and make it easier for healthcare companies to start closing more deals.
Our customers use a range of search and bid-development tools within our platform to quickly find the most suitable opportunity and finalise a transaction. We have millions of contracts in our platform across countries for suppliers to bid, we have onboarded some of the world’s most innovative healthcare companies, we are continuing to raise money to build the world’s first digital marketplace, we have won innovation awards, and we’re backed by some of the best investors in the world.
And we are JUST GETTING STARTED.. .
Fitore offers health products built with science. This Denver-based startup aims to radically transform human health through advanced bionutraceautical products.
A bionutraceutical is an all-natural, pharmaceutical-grade formulation developed from technology based on biology. Fitore has partnered with the leaders in stem science—Vitro Biopharma to reveal that reversing the effects of aging is now feasible..
Pure Scientific Technologies
Pure Scientific Technologies is a medical device startup company that develops a new patent-pending drug delivery system. The system is designed to deliver a wide variety of pharmaceuticals and CBD into the lungs with greater efficiency than existing technology.
It utilizes Heliox as a primary carrier gas that offers the opportunity for a more efficient and more comfortable respiratory treatment. The device is designed and developed to replace conventional inhalers and nebulizers and is designed to effectuate the rapid and measured delivery in its purest form of the desired pharmaceutical directly into the lungs generally utilizing a mixture of helium and oxygen (”Heliox”) to carry the chemically active pharmaceutical (liquid or powder) directly into the bloodstream to treat lung disease and other conditions.
It was established in Las Vegas, Nevada in 2020.. .
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus.
The patch is applied like a Band-Aid and remains on the skin for less than an hour. During that time, the microneedles, which are composed of the immune-stimulators in a sustained-release polymer matrix, dissolve from the adhesive backing and are implanted into the skin.
The adhesive can then be removed leaving the microneedles to dissolve in the skin over weeks. During that time, immune stimulators are steadily released directly into the wart.
The San Antonio, Texas-located company was founded in 2019 by Lauren Durso, Reid Waldman, Ming Lee, Madeline DeWane, and Kyle Ryder.. .
XRnanotech is an award-winning Swiss deep tech company. We offer innovative nanostructured X-ray optics with outstanding precision for high-tech applications.
Our optics allow focusing ever higher-energy beams onto the smallest possible samples. This is crucial for drug discovery, medical imaging, microchip inspection, or investigation of advanced materials.
In this niche, we provide unique solutions for several hundred large-scale R&D beamlines and high-tech companies around the world. Our vision is to enable them to analyze yet unmeasurable nano-systems..
Animal Life Sciences
Animal Life Sciences operates as a nutritional and pharmaceutical development company. It focuses on licensing, development, and commercialization of safe and effective treatments for cats and dogs based on cutting edge human cancer technologies.
The company was founded in 2019 and is headquartered in Houston, Texas.. .
Altis is a clinical information company advancing medical research and knowledge. Our team is on a mission to guide personalized treatment and accelerate therapeutic R&D with deep learning-based imaging biomarkers made accessible via our software platform, Nota.
Nota enables researchers to operationalize imaging data and leverage predictive imaging insights at scale. Leading biopharmaceutical companies use Nota to accelerate and optimize R&D of their most promising therapies across all stages of clinical development.
Altis is headquartered in Toronto, a city recognized for its deep learning research and renowned medical institutions.. .
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well as safe and effective TCRs against these tumour targets for therapeutic application.
Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.. .
A Biotech start-up focused on developing new science-based products. Immunotherapies and Orally passive immunization is our cup of tea.
Nowadays we are working on a new therapy to improve life quality in Crohn´s Disease patients and improving a new methodology to reduce the use of antibiotics in hospitalized elderly patients.. .
GeneralHealth Group Inc
GeneralHealth Group Inc is a company registered in Florida, USA. We are a healthcare consolidation company with strong leadership and vision which aspires us to become the global leader in healthcare and innovation.
GeneralHealth Group works on the foundation for individuals and families to flourish, communities to prosper and nations to thrive by enhancing health, a fundamental human right. Countries in Southeast Asia are in the stages of developing their healthcare systems.
A typology of common issues, challenges, and priorities are generated for the diverse mix of health systems at different stages of socio-economic development. However, crucial issues involve rising costs, future sustainability of centralized tax-financed systems, efficiency, and quality of the public services, and higher public expectations.
Smaller businesses struggle to play in these numerical asymmetries and get fumbled between ensuring quality and controlling costs. We consolidate and nurture these businesses with our experienced team to help them have a strong united position in the changing face of a promising industry.
Failure of businesses is likely highly disruptive to the remaining, typically financially vulnerable, customer base, as well as the business owners themselves. Many SMB professionals are firm owners, direct practitioners, and GPs approaching retirement age and directly involved in day-to-day operations.
Motivation to find viable exit strategies remains constant across the industry, accelerated by the pandemic. Health care market opportunities are increasingly driven by the need to provide high-quality service, competitive costs, and maintain retention rates, and avoid financial penalties.
flipMD is an open, competitive marketplace of physicians offering their skills, knowledge, and expertise to a wide range of clients and industries. Industries served include admissions consulting, expert witness, medical device, investing consulting, medical writing, startup/tech consulting, PR/marketing, etc.
The ultimate goal of flipMD is to be the ultimate source of physician talent for any industry. The platform is straightforward to use, a client posts a job for free with the specific scope of work and their budget.
Our physicians then compete for the job and complete it in a timely fashion and deliver high-quality results within the client’s budget.. .